NAFDAC Warn Nigerians As ‘Fake’ AstraZeneca Vaccines Hit Market


The National Agency for Food and Drug Administration and Control has warned Nigerians to be wary of the type COVID-19 AstraZeneca Vaccine being administered on them.

Addressing the nation in a statement made available to newsmen earlier, NAFDAC Director-General, Prof. Mojisola Adeyeye, said it became necessary for citizens to ensure that they are not being vaccinated with the fake version of the AstraZeneca vaccine.

Read Also: #Health: New Disease Hits #Kano, Leaves At least Fifty-Six People Hospitalized

According to her, the original Oxford Astrazeneca University vaccine had been contracted to India’s world largest vaccine manufacturer, Serum Institute of India (SIIPL), to produce in large quantity.

“AZOU gave the licence of its vaccine to Serum Institute of India PVT Limited to manufacture this vaccine at a commercial scale. SIIPL is the largest vaccine manufacturer in the world and the company got the licence by signing the manufacturing agreement,” Mrs Adeyeye noted.

Read Also: Why Kogi Is Yet To Receive COVID-19 Vaccines – PTF

Her statement reads further: “The SIIPL gave the vaccine the trade name COVISHIELD; it is the result of cooperation and a technology transfer from AstraZeneca – University of Oxford to SIIPL.

“The SIIPL is now the world’s largest vaccine manufacturer by the number of doses produced and sold globally; more than 1.5 billion doses, which include Polio vaccine, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella.”

Read Also: Over 2 Million Nigerians Registered In Less Than 24 Hours Following Arrival Of COVID-19 Vaccine – Healthcare Agency

Mrs Adeyeye explained further that the vaccines manufactured by SIIPL were accredited by the World Health Organisation, and were being used in about 170 countries across the globe in their national immunisation programme. The NAFDAC DG said both COVISHIELD manufactured by SIIPL and COVID-19 vaccine AstraZeneca, manufactured by AstraZeneca/Oxford University vaccine are the same vaccine.

Read Also: AstraZeneca Vaccines Will Be Deployed To Vaccinate Critical Frontline Health Care Workers – NPHCDA

“ChAdOx1 nCoV-19 coronavirus vaccines (Recombinant), COVISHIELD, was granted Emergency Use Listing (EUL) by the World Health Organisation on February 15, and that it was one of the listed vaccines under the COVAX Facility,” Adeyeye added.

Abubakar made this known during a meeting with members of the Presidential Taskforce (PTF) on COVID-19 in Abuja on Friday.


Please enter your comment!
Please enter your name here